Omkar Bhatavdekar, Inês Godet, Daniele Gilkes, & Stavroula Sofou. (2022). The Rate of Cisplatin Dosing Affects the Resistance and Metastatic Potential of Triple Negative Breast Cancer Cells, Independent of Hypoxia. MDPI AG.
Chicago Style (17th ed.) CitationOmkar Bhatavdekar, Inês Godet, Daniele Gilkes, and Stavroula Sofou. The Rate of Cisplatin Dosing Affects the Resistance and Metastatic Potential of Triple Negative Breast Cancer Cells, Independent of Hypoxia. MDPI AG, 2022.
MLA (9th ed.) CitationOmkar Bhatavdekar, et al. The Rate of Cisplatin Dosing Affects the Resistance and Metastatic Potential of Triple Negative Breast Cancer Cells, Independent of Hypoxia. MDPI AG, 2022.
Warning: These citations may not always be 100% accurate.